PTSM: Pharmaceutical Technology Sourcing and Management-02-04-2015

In-house biologics fill/finish operations have invested in new technologies and have available capacity while small-molecule fill-finish facilities work at near-capacity on legacy equipment.

Experts review considerations for selecting excipients for solid-dosage drug performance and manufacturability.

Better barrier materials and software modeling streamline the blister-package design process.

Custom API manufacturers firms that offer specialized capabilities will benefit from the continuing trend toward pharmaceutical outsourcing.

Catalent will add potent containment for blending and granulation at its New Jersey manufacturing Center of Excellence.

PPD announced that it completed an expansion to its Athlone, Ireland facility, resulting in 20,000-square-feet of dedicated space for warehousing and distribution purposes.

FDA has approved the Ash Steven’s manufacturing facility in Riverview, MI for the manufacture of Amotosalen.

The new facility will feature dry powder cell-culture media capabilities.

The new facility will feature new research and development capabilities.

The acquisition of Aptuit's Glasgow, UK and Indiana, US facilities will add sterile injectable formulation development and expand AMRI's analytical services capabilities.